Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-06 | New | $7,399,999 | Unknown | Equity Only | SEC link | |
| 2024-12-05 | New | $5,543,624 | $5,543,624 | Equity Only | 06b | SEC link |
| 2024-09-13 | Amended | $1,850,000 | $0 | Debt Only | 06b | SEC link |
| 2024-07-23 | Amended | $1,850,000 | $0 | Debt Only | 06b | SEC link |
| 2024-06-12 | New | $1,850,000 | $1,850,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Nicole Bergman | Director |
| Colin Cook | Director |
| Christopher Thanos | Director, Executive |